Cargando…

Construction and validation of a predictive model for hepatocellular carcinoma based on serum markers

BACKGROUND: Early hepatocellular carcinoma (HCC) detection with non-invasive biomarkers remains an unmet clinical need. We aimed to construct a predictive model based on the pre-diagnostic levels of serum markers to predict the early-stage onset of HCC. METHODS: A total of 339 HCC patients (includin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Liming, Huang, Zeyu, Li, Xiaoping, He, Meifang, Liu, Xiaoqin, Zheng, Guojun, Zhou, Xike, Liu, Longgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472335/ https://www.ncbi.nlm.nih.gov/pubmed/36100887 http://dx.doi.org/10.1186/s12876-022-02489-2

Ejemplares similares

Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
por: Zheng, Liming, et al.
Publicado: (2021)

SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose
por: Zhang, Xiujun, et al.
Publicado: (2022)

The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma
por: Li, Bo, et al.
Publicado: (2017)

Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients
por: Liu, Kang, et al.
Publicado: (2020)

Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma
por: Tian, Siyuan, et al.
Publicado: (2021)

Association of Non-Invasive Markers with Significant Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study
por: Zhang, Fan, et al.
Publicado: (2023)

Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2015)

Construction and Validation of a Nomogram for Predicting the Risk of Deep Vein Thrombosis in Hepatocellular Carcinoma Patients After Laparoscopic Hepatectomy: A Retrospective Study
por: Chen, Yao, et al.
Publicado: (2021)

Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2021)

Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma
por: Liu, Weifeng, et al.
Publicado: (2017)

Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma
por: Zheng, Chunlan, et al.
Publicado: (2023)

Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Ramachandran, Prasanna, et al.
Publicado: (2022)

Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers
por: Braicu, Cornelia, et al.
Publicado: (2009)

Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma
por: Shen, Yinghao, et al.
Publicado: (2015)

Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients
por: Liu, Yunxun, et al.
Publicado: (2023)

Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2022)

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
por: Debes, José D., et al.
Publicado: (2021)

Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers
por: Seino, Satoshi, et al.
Publicado: (2018)

Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma
por: Zhang, Jia, et al.
Publicado: (2019)

An Autophagy-Related Gene-Based Prognostic Risk Signature for Hepatocellular Carcinoma: Construction and Validation
por: Feng, Rui, et al.
Publicado: (2021)

Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case–control study
por: Zhang, Sheng, et al.
Publicado: (2019)

Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma
por: Xu, Lijun, et al.
Publicado: (2022)

Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma
por: Peng, Yue-ling, et al.
Publicado: (2023)

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma
por: Liu, Tianhui, et al.
Publicado: (2017)

Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects
por: Zhang, Sheng, et al.
Publicado: (2020)

Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma
por: Zong, Jingjing, et al.
Publicado: (2020)

Correction: Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma
Publicado: (2015)

Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo
por: Liu, Gang, et al.
Publicado: (2016)

Construction and validation of a pyroptosis-related gene signature in hepatocellular carcinoma based on RNA sequencing
por: He, Jiaming, et al.
Publicado: (2022)

Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
por: Xu, Linfeng, et al.
Publicado: (2021)

Construction and validation of a prediction model of extrahepatic metastasis for hepatocellular carcinoma based on common clinically available data
por: Zhou, Liuxin, et al.
Publicado: (2022)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma
por: Li, Guanqun, et al.
Publicado: (2022)

Prognostic significance of LRRC1 in hepatocellular carcinoma and construction of relevant prognostic model
por: Cai, Qingshan, et al.
Publicado: (2023)

Comparison of the methods for profiling N-glycans—hepatocellular carcinoma serum glycomics study
por: Wang, Ran, et al.
Publicado: (2018)

Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival
por: Liu, Pulin, et al.
Publicado: (2022)

Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related Genes
por: Yu, Jiahao, et al.
Publicado: (2021)

Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis
por: He, Qifan, et al.
Publicado: (2022)

Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s8ons838d4e1r3gj4ucv1gse9c